Related Experiment Video
Updated: Aug 17, 2026
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Insights
Bronchopulmonary dysplasia is a chronic lung disease in newborns treated with mechanical ventilation and oxygen. While it causes significant health issues, it typically improves over time with supportive care.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Developmental Biology
Background:
- Neonatal pulmonary diseases often necessitate mechanical ventilation and supplemental oxygen.
- These interventions can harm the immature lung and disrupt normal lung maturation.
- Bronchopulmonary dysplasia (BPD) is a significant consequence of these therapies.
Purpose of the Study:
- To describe the pathological process and clinical course of bronchopulmonary dysplasia.
- To highlight the morbidity and mortality associated with BPD in early life.
- To outline the supportive management and long-term prognosis of BPD.
Main Methods:
- The abstract describes the pathological sequence of lung injury and repair in BPD.
- It outlines the clinical manifestations, including growth delay and respiratory insufficiency.
- The study reviews the typical therapeutic approach and disease resolution.
Main Results:
- The development of BPD involves acute hyaline membrane formation, pulmonary edema, interstitial fibrosis, and emphysema.
- BPD is associated with significant morbidity and mortality in the first two years of life.
- Clinical symptoms and radiographic findings often improve over time.
Conclusions:
- Bronchopulmonary dysplasia is a complex developmental lung injury resulting from neonatal respiratory support.
- While associated with severe early-life complications, BPD tends to resolve slowly with supportive care.
- Most patients experience mild or no residual pulmonary dysfunction later in life.
Abstract:
Neonatal pulmonary diseases may require mechanical ventilation and supplemental oxygen therapy. These supportive measures can damage the immature lung or distort the normal maturation processes of the developing lung. The formation of hyaline membranes occurs acutely, often complicated by left-to-right cardiac shunts. Pulmonary edema occurs next, followed by interstitial fibrosis and finally by parenchymal emphysema. This process is termed bronchopulmonary dysplasia. Significant morbidity and mortality are associated with this developmental pulmonary dysplasia, particularly during the first two years of life. A delay in normal growth and development is often present, acute episodes of pulmonary insufficiency are seen, and multiple episodes of pulmonary infection occur. Subsequently, the radiographic appearance and the clinical symptoms improve. Therapy is mainly supportive throughout the course of the disease and the bronchopulmonary dysplasia tends to resolve slowly. Residual pulmonary dysfunction is usually mild or absent.
Related Concept Videos
01:17Pulmonary Cycle: Exhalation
01:24Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:23Chronic Obstructive Pulmonary Disease I: Introduction
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features